Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Covington
Cipla
Boehringer Ingelheim
Chubb
Deloitte
Federal Trade Commission
Colorcon
Moodys

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075205

« Back to Dashboard

NDA 075205 describes CLOBETASOL PROPIONATE, which is a drug marketed by Ingenus Pharms Llc, Perrigo Israel, Fougera Pharms Inc, G And W Labs Inc, Lupin Ltd, Mylan Pharms Inc, Taro, Teva Pharms Usa, Fougera Pharms, Perrigo Co, Teligent Pharma Inc, Actavis Mid Atlantic, Glenmark Pharms, Zydus Pharms Usa Inc, Hi-tech Pharmacal, Macleods Pharms Ltd, Novel Labs Inc, Tolmar, Wockhardt Bio Ag, Akorn, Paddock Llc, and Novast Labs Ltd, and is included in forty-five NDAs. It is available from thirty-two suppliers. Additional details are available on the CLOBETASOL PROPIONATE profile page.

The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are thirteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 075205
Tradename:CLOBETASOL PROPIONATE
Applicant:Wockhardt Bio Ag
Ingredient:clobetasol propionate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 075205
Medical Subject Heading (MeSH) Categories for 075205
Suppliers and Packaging for NDA: 075205
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOBETASOL PROPIONATE clobetasol propionate SOLUTION;TOPICAL 075205 ANDA Rebel Distributors Corp 21695-358 E 21695-358-25
CLOBETASOL PROPIONATE clobetasol propionate SOLUTION;TOPICAL 075205 ANDA Morton Grove Pharmaceuticals, Inc. 60432-133 N 60432-133-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;TOPICALStrength0.05%
Approval Date:Nov 13, 1998TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
AstraZeneca
Queensland Health
Boehringer Ingelheim
Cerilliant
Cipla
Johnson and Johnson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.